Abstract
All experts involved in the development of these guidelines have submitted declarations of interest. These have been compiled in a report and published in a supplementary document simultaneously to the guidelines. The report is also available on the ESC website www.escardio.org/guidelines (C) For the Supplementary Data which include background information and detailed discussion of the data that have provided the basis for the guidelines see European Heart Journal online
| Original language | English |
|---|---|
| Pages (from-to) | 4-131 |
| Number of pages | 128 |
| Journal | European journal of heart failure |
| Volume | 24 |
| Issue number | 1 |
| DOIs | |
| Publication status | Published - 1 Jan 2022 |
Keywords
- Guidelines
- heart failure
- natriuretic peptides
- ejection fraction
- diagnosis
- pharmacotherapy
- neuro-hormonal antagonists
- cardiac resynchronization therapy
- mechanical circulatory support
- transplantation
- arrhythmias
- comorbidities
- hospitalization
- multidisciplinary management
- advanced heart failure
- acute heart failure
- CARDIAC-RESYNCHRONIZATION THERAPY
- PRESERVED EJECTION FRACTION
- VENTRICULAR ASSIST DEVICE
- QUALITY-OF-LIFE
- IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR
- AORTIC-VALVE-REPLACEMENT
- CORONARY-ARTERY-DISEASE
- ACUTE MYOCARDIAL-INFARCTION
- BRAIN NATRIURETIC PEPTIDE
- WORSENING RENAL-FUNCTION
Fingerprint
Dive into the research topics of '2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure Developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) With the special contribution of the Heart Failure Association (HFA) of the ESC'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver